Donor Lymphocyte Infusion Post-Transplant
Preemptive Infusion of Donor Lymphocytes Depleted of TCR (Alpha-beta) + T Cells and CD19+ B Cells Following Allogeneic Stem Cell Transplantation
More Information
- Trial Status
- Not yet accepting
- Trial Phase
- Phase 1
- Enrollment
- 10 patients (estimated)
- Sponsors
- Case Comprehensive Cancer Center
- Tags
- Donor Lymphocyte Infusion (DLI)
- Trial Type
- Treatment
- Last Update
- 2 weeks ago
- SparkCures ID
- 1590
- NCT Identifier
- NCT03939585
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.